Changes of glomerular filtration rate and renal plasma flow following intravenous bumetanide in organic heart disease.
D001565:Benzoates / Q000008:administration & dosage / Q000494:pharmacology*; D002082:Butylamines / Q000008:administration & dosage / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects; D004232:Diuretics / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D005919:Glomerular Filtration Rate; D006333:Heart Failure / Q000188:drug therapy; D006801:Humans; D007275:Injections, Intravenous; D007668:Kidney / Q000098:blood supply* / Q000187:drug effects; D008297:Male; D010647:Phenyl Ethers / Q000008:administration & dosage / Q000494:pharmacology; D012039:Regional Blood Flow / Q000187:drug effects; D012964:Sodium / Q000652:urine; D013268:Stimulation, Chemical; D013449:Sulfonamides; D013997:Time Factors; D014882:Water-Electrolyte Balance / Q000187:drug effects
D001565:Benzoates; D002082:Butylamines; D004232:Diuretics; D010647:Phenyl Ethers; D013449:Sulfonamides; D012964:Sodium